Nasdaq Stockholm

Annexin Pharmaceuticals AB (publ)

ISIN SE0009664154Filings at the FI

At a glance

Most recent filing on March 17, 2022 — an open-market purchase by Uli Hacksell on Mar 15, 2022.

We hold 8 visible filings, going back to March 11, 2019.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 8 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 8. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Uli Hacksell Chair of the board
86,900 SEKOpen-market buy
TradedMar 15, 2022FiledMar 17, 2022
Carl-Fredrik Lindner Chair of the board
3,850 SEKOpen-market buy
TradedDec 23, 2020FiledDec 24, 2020
Carl-Fredrik Lindner Chair of the board
73,238 SEKOpen-market buy
TradedDec 23, 2020FiledDec 24, 2020
Carl-Fredrik Lindner Chair of the board
53,396 SEKOpen-market buy
TradedDec 23, 2020FiledDec 24, 2020
Carl-Fredrik Lindner Chair of the board
3,850 SEKOpen-market buy
TradedDec 23, 2020FiledDec 24, 2020